The Harvard Drug Group has recalled 3,984 cartons of Gabapentin (gabapentin) Tablets, USP 600 mg distributed by Major Pharmaceuticals and Aurobindo Pharma USA. The recall was issued after a single foreign tablet was discovered in a package, indicating a potential product mixup during packaging. No incidents or injuries have been reported to date. If you have this medication, you should consult with your healthcare provider or pharmacist.
A product mixup means a patient might inadvertently take a medication other than the one prescribed, which could lead to unexpected side effects or a failure to treat the intended condition. No injuries have been reported in connection with this specific incident.
You have 2 options:
Distributed by Aurobindo Pharma USA, Inc. and Major Pharmaceuticals. Packaged in 10 blister packs of 10 tablets.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.